Scarica l'app Stockscreener
2.39
2.85%
-0.07
Anebulo Pharmaceuticals Inc Azioni (ANEB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-03-31 | 2023-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
26.89%
1.8923
|
2.5882 | 2.4121 | 1.6643 | 2.7605 |
| Interest Income/Expense |
0.10
|
- | - | - | - |
| Operating Income/Loss |
26.89%
-1.8923
|
-2.5882 | -2.4121 | -1.6643 | -2.7605 |
| Nonoperating Income/Loss |
72.76%
0.2162
|
0.1251 | 0.2114 | 0.0107 | 0.0431 |
| Income/Loss From Continuing Operations Before Tax |
31.95%
-1.6762
|
-2.463 | -2.2007 | -1.6535 | -2.7174 |
| Income/Loss From Continuing Operations After Tax |
31.95%
-1.6762
|
-2.463 | -2.2007 | -1.6535 | -2.7174 |
|
Net Income/Loss
|
31.95%
-1.6762
|
-2.463 | -2.2007 | -1.6535 | -2.7174 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
49.86%
41.08
|
27.42 | 25.93 | 25.93 | 25.79 |
| Diluted Average Shares |
49.86%
41.08
|
27.42 | 25.93 | 25.93 | 25.79 |
| Basic Earnings Per Share |
55.56%
-0.04
|
-0.09 | -0.08 | -0.06 | -0.11 |
| Diluted Earnings Per Share |
55.56%
-0.04
|
-0.09 | -0.08 | -0.06 | -0.11 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):